Amplia Therapeutics Limited

INNMF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$0-$4,503-$6,242-$3,644
Dep. & Amort.$0$86$73$3
Deferred Tax$0$0$314-$889
Stock-Based Comp.$0$0$209$61
Change in WC-$668-$2,045$670-$822
Other Non-Cash-$6,218$1,335-$313$889
Operating Cash Flow-$6,886-$5,127-$5,290-$4,402
Investing Activities
PP&E Inv.-$2-$2-$18-$14
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$41-$12
Investing Cash Flow-$2-$2-$58-$27
Financing Activities
Debt Repay.-$1,550-$633-$65$2,100
Stock Issued$17,281$0$21$16,271
Stock Repurch.-$1,330$0$0-$1,182
Dividends Paid$0$0$0$0
Other Fin. Act.-$81-$140-$41$0
Financing Cash Flow$14,320-$773-$84$17,189
Forex Effect$46$31$80-$0
Net Chg. in Cash$7,478-$5,871-$5,352$12,760
Supplemental Information
Beg. Cash$3,385$9,257$14,609$1,848
End Cash$10,863$3,385$9,257$14,609
Free Cash Flow-$6,888-$5,129-$5,307-$4,416
Amplia Therapeutics Limited (INNMF) Financial Statements & Key Stats | AlphaPilot